Literature DB >> 15478062

Molecular epidemiology of hepatitis C virus in a social network of injection drug users.

Campbell K Aitken1, Rhonda F McCaw, D Scott Bowden, Samantha L Tracy, Jenny G Kelsall, Peter G Higgs, Michael J Kerger, Hoang Nguyen, J Nick Crofts.   

Abstract

BACKGROUND: We aimed to measure the overlap between the social networks of injection drug users (IDUs) and the patterns of related hepatitis C virus (HCV) infections among IDUs.
METHODS: A cohort of 199 IDUs (138 of whom were HCV RNA positive) was recruited from a local drug scene in Melbourne, Australia, and was studied using social network analysis and molecular phylogenetic analysis of 2 regions of the HCV genome.
RESULTS: Eighteen clusters of related infections involving 51 IDUs (37.0% of HCV RNA-positive IDUs) were detected; these clusters could be separated into 66 discrete pairs. Twelve (18.2%) of the 66 IDU pairs with related infections reported having previously injected drugs together; conversely, only 12 (3.8%) of the 313 pairs of HCV RNA-positive IDUs who were injection partners had strong molecular evidence of related infections. The social and genetic distances that separated IDUs with identical genotypes were weakly associated. Significant clusters of phylogenetically related sequences identified from core region analysis persisted in the analysis of the nonstructural 5a protein region. Genotyping and sequence analysis revealed 2 mixed-genotype infections.
CONCLUSIONS: Static social network methods are likely to gather information about a minority of patterns of HCV transmission, because of the difficulty of determining historical infection pathways in an established social network of IDUs. Nevertheless, molecular epidemiological methods identified clusters of IDUs with related viruses and provided information about mixed-genotype infection status.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15478062     DOI: 10.1086/424678

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

1.  Inconsistent temporal patterns of genetic variation of HCV among high-risk subjects may impact inference of transmission networks.

Authors:  Rebecca Rose; Christopher Rodriguez; James Jarad Dollar; Susanna L Lamers; Guido Massaccesi; William Osburn; Stuart C Ray; David L Thomas; Andrea L Cox; Oliver Laeyendecker
Journal:  Infect Genet Evol       Date:  2019-02-22       Impact factor: 3.342

2.  Differences in the social networks of ethnic Vietnamese and non-Vietnamese injecting drug users and their implications for blood-borne virus transmission.

Authors:  C K Aitken; P Higgs; S Bowden
Journal:  Epidemiol Infect       Date:  2007-05-17       Impact factor: 2.451

3.  Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada.

Authors:  Evan B Cunningham; Brendan Jacka; Kora DeBeck; Tanya L Applegate; P Richard Harrigan; Mel Krajden; Brandon D L Marshall; Julio Montaner; Viviane Dias Lima; Andrea D Olmstead; M-J Milloy; Evan Wood; Jason Grebely
Journal:  Drug Alcohol Depend       Date:  2015-04-20       Impact factor: 4.492

4.  A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies.

Authors:  Tanya L Applegate; Jason Grebely; Sofia R Bartlett; Joel O Wertheim; Rowena A Bull; Gail V Matthews; Francois Mj Lamoury; Konrad Scheffler; Margaret Hellard; Lisa Maher; Gregory J Dore; Andrew R Lloyd
Journal:  J Viral Hepat       Date:  2016-11-24       Impact factor: 3.728

5.  Complex patterns of Hepatitis-C virus longitudinal clustering in a high-risk population.

Authors:  Rebecca Rose; Susanna L Lamers; Guido Massaccesi; William Osburn; Stuart C Ray; David L Thomas; Andrea L Cox; Oliver Laeyendecker
Journal:  Infect Genet Evol       Date:  2017-12-16       Impact factor: 3.342

6.  Staphylococcus aureus colonization and infection among drug users: identification of hidden networks.

Authors:  Robert A Gwizdala; Maureen Miller; Meera Bhat; Peter Vavagiakis; Christopher Henry; Alan Neaigus; Qiuhu Shi; Franklin D Lowy
Journal:  Am J Public Health       Date:  2011-07       Impact factor: 9.308

7.  Social networks and HCV viraemia in anti-HCV-positive rural drug users.

Authors:  A M Young; A B Jonas; J R Havens
Journal:  Epidemiol Infect       Date:  2012-04-19       Impact factor: 2.451

8.  A Phylogenetic Analysis of Hepatitis C Virus Transmission, Relapse, and Reinfection Among People Who Inject Drugs Receiving Opioid Agonist Therapy.

Authors:  Matthew J Akiyama; Daniel Lipsey; Lilia Ganova-Raeva; Lili T Punkova; Linda Agyemang; Amanda Sue; Sumathi Ramachandran; Yury Khudyakov; Alain H Litwin
Journal:  J Infect Dis       Date:  2020-07-06       Impact factor: 5.226

Review 9.  Modeling hepatitis C virus transmission among people who inject drugs: Assumptions, limitations and future challenges.

Authors:  Nick Scott; Margaret Hellard; Emma Sue McBryde
Journal:  Virulence       Date:  2015-08-25       Impact factor: 5.882

10.  HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection.

Authors:  Sofia R Bartlett; Brendan Jacka; Rowena A Bull; Fabio Luciani; Gail V Matthews; Francois M J Lamoury; Margaret E Hellard; Behzad Hajarizadeh; Suzy Teutsch; Bethany White; Lisa Maher; Gregory J Dore; Andrew R Lloyd; Jason Grebely; Tanya L Applegate
Journal:  Infect Genet Evol       Date:  2015-11-26       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.